Production of a functional human acid maltase in tobacco seeds; biochemical analysis, uptake by human GSDII cells and in vivo studies in GAA knockout mice.

Matteo Busconi, Frank Martiniuk, Serena Reggi, Kam-Meng Tchou-Wong, William N. Rom, Corrado Fogher

Risultato della ricerca: Contributo in rivistaArticolo in rivistapeer review

6 Citazioni (Scopus)

Abstract

Genetic deficiency of acid alpha glucosidase (GAA) results in glycogen storage disease type II (GSDII) or Pompe’s disease. To investigate whether we could generate a functional recombinant human GAA enzyme (tobrhGAA) in tobacco seeds for future enzyme replacement therapy, we subcloned the human GAA cDNA into the plant expression plasmid-pBI101 under the control of the soybean β-conglycinin seed-specific promoter and biochemically analyzed the tobrhGAA. Tobacco seeds contain the metabolic machinery that is more compatible with mammalian glycosylation−phosphorylation and processing. We found the tobrhGAA to be enzymatically active was readily taken up by GSDII fibroblasts and in white blood cells from whole blood to reverse the defect. The tobrhGAA corrected the enzyme defect in tissues at 7 days after a single dose following intraperitoneal (IP) administration in GAA knockout (GAA−/−) mice. Additionally, we could purify the tobrhGAA since it bound tightly to the matrix of Sephadex G100 and can be eluted by competition with maltose.
Lingua originaleEnglish
pagine (da-a)N/A-N/A
RivistaApplied Biochemistry and Biotechnology
DOI
Stato di pubblicazionePubblicato - 2013

Keywords

  • Enzyme replacement
  • Pompe’s disease
  • Recombinant human acid maltase
  • Transgenic tobacco plants

Fingerprint

Entra nei temi di ricerca di 'Production of a functional human acid maltase in tobacco seeds; biochemical analysis, uptake by human GSDII cells and in vivo studies in GAA knockout mice.'. Insieme formano una fingerprint unica.

Cita questo